Latent vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-10-11
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionLatentIsomorphic Labs
PricingContact for quoteContact for quote
Primary FocusAutomate medication access for health systems (prior auth, specialty pharmacy)AI drug discovery for pharma partners (molecule design, protein simulation)
Target UserHealth system pharmacy leaders, CPOs, prior auth teamsLarge pharma companies, drug development programs
Key TechnologyAgentic engine for workflow automation, medical language models, CIPHER (PHI-safe LLM)AlphaFold-based predictive models, generative AI for novel molecules, Drug Design Engine
Best ForHealth systems needing to reduce admin burden and improve medication accessPharma companies seeking AI-accelerated drug discovery partnerships
Latent
Latent

Latent is an enterprise pharmacy intelligence platform for large health systems, automating prior authorization, specialty fill capture, and medication access.

Visit Website
Isomorphic Labs
Isomorphic Labs

Isomorphic Labs uses AI drug discovery models to design novel molecules and predict how candidate drugs will perform.

Visit Website
Pricing
Contact Sales
Contact Sales
Plans
—
—
Popularity
4 views
7.5k views
Skill Level
Advanced
Advanced
API Available
Platforms
Web
—
Categories
🧾 Healthcare Revenue Cycle🏥 Healthcare
🧬 Drug Discovery & Life Sciences
Features
Clinical agentic engine automating end-to-end medication access workflows
Automated prior authorization submission, tracking, and status follow-up
Population scanning to identify patients with medication care gaps
Payer policy parsing and medical necessity checking
Appeal drafting cut from 30 minutes of pharmacist time to 7
Automated reauthorization processing cutting workload roughly 50%
Real-time specialty fill capture and in-house revenue tracking
Copay assistance program matching, $50M secured for patients
Patient engagement with routing to clinical pharmacists
GLP-1 Bridge support for Medicare's GLP-1 Bridge program (added July 2026)
CIPHER 1.5B-parameter clinical de-identification model, 97.9% PHI recall
CIPHER inference at ~50ms per document and ~1/1000th frontier LLM inference cost
Native EHR integration including Epic and Cerner
Analytics dashboard for prior auth throughput and specialty capture
SOC 2 and HIPAA compliant data handling
Drug Design Engine spanning generative molecule design through lead optimization
Predictive AI models that anticipate how candidate drugs will perform
Generative models for designing novel molecules
Built on and beyond the Nobel-winning AlphaFold system
End-to-end research collaborations from target identification to lead optimization
Digital biology approach aimed at discovery at digital speed
Named pharma partners include Johnson & Johnson, Novartis and Eli Lilly
Joined the Virtual Biology Initiative to build foundational data for AI disease models
Funder of Biohub's $1.8B initiative to train AI models that predict cell behavior
Bioresilience framework for biological threats and health emergencies
Announced a new path to making medicines with AI
Series B announced May 2026 to scale the Drug Design Engine
Follows a $600M external raise in March 2025
President Max Jaderberg appointed November 2025 to integrate AI and science
Founded by Demis Hassabis, who serves as CEO
Integrations
Epic
Cerner

Who should pick which

  • Chief Pharmacy Officer at a large hospital system
    Pick: Latent

    Latent directly addresses prior auth bottlenecks and medication access gaps, integrating with your existing EHR and pharmacy systems to increase throughput by 109%.

  • VP of R&D at a top-20 pharma company
    Pick: Isomorphic Labs

    Isomorphic Labs' AlphaFold-based Drug Design Engine and generative AI can accelerate your lead optimization, backed by partnerships with Novartis and J&J.

  • Clinical pharmacist at a community hospital
    Pick: Latent

    Latent automates time-consuming prior auths and appeal drafting, freeing you to focus on patient care, with proven EHR integration.

  • Biotech startup exploring AI drug discovery
    Pick: Isomorphic Labs

    If you can afford a deep partnership, Isomorphic Labs offers cutting-edge generative and predictive models for novel molecule design, though smaller firms may find the cost prohibitive.

  • Health system CFO evaluating ROI on automation
    Pick: Latent

    Latent claims $300K annual labor cost avoidance and 85% specialty fill capture, directly impacting revenue and operational efficiency.

Frequently Asked Questions

Can I use Latent as a standalone AI chatbot?

No, Latent is an enterprise platform for health system pharmacy operations, not a generic chatbot.

Does Isomorphic Labs sell software or APIs?

No, it only operates through deep pharma partnerships and does not offer off-the-shelf products.

Which tool integrates with Epic EHR?

Latent integrates with Epic, Cerner, and other major EHR and pharmacy systems.

Is AlphaFold available through Isomorphic Labs?

AlphaFold underpins Isomorphic's Drug Design Engine, but access is exclusive to pharma partners.

What is Latent's CIPHER model?

CIPHER 1.5B is a PHI-safe language model with 97.9% recall, designed for clinical deidentification at low cost.

Has Isomorphic Labs announced recent funding?

Yes, a $600M external round in 2025 and a Series B in February 2026 (amount undisclosed).

Can Latent help with GLP-1 drugs?

Yes, Latent launched 'GLP-1 Bridge' in July 2026 to manage Medicare eligibility for ~$50/month drugs.

Who are Isomorphic Labs' partners?

Novartis and Johnson & Johnson.

More Latent or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026